首页> 外国专利> Process for controlling the accuracy and precision of sensitivity assays

Process for controlling the accuracy and precision of sensitivity assays

机译:控制灵敏度测定的准确性和精确度的过程

摘要

A method of determining the relative clinical potency of a test agent, such as a chemotherapeutic drug or radiation, on cells from an individual. A plurality of assay cell samples from the individual are treated with a different doses of the agent, and the growth of the cell samples measured. An "inhibitory value" is then calculated, which is the value of one of the dose and dose response, corresponding to a selected value of the other one. For drug testing, the inhibitory value is preferably the value of the dose which produces a dose response selected at a 90% kill. The inhibitory value can then be compared with inhibitory values for cells from a plurality of other individuals to ascertain the relative clinical potency of the test agent. A number of techniques are provided which reduce errors associated with such assays so that meaningful comparisons can be made.
机译:一种确定测试剂(例如化学治疗药物或放射线)在个体细胞上的相对临床效力的方法。用不同剂量的试剂处理来自个体的多个测定细胞样品,并测量细胞样品的生长。然后计算“抑制值”,其是剂量和剂量响应之一的值,对应于另一个的选择值。对于药物测试,抑制值优选是产生以90%杀灭率选择的剂量反应的剂量值。然后可以将抑制值与来自多个其他个体的细胞的抑制值进行比较,以确定测试剂的相对临床效力。提供了许多减少与此类测定法相关的误差的技术,从而可以进行有意义的比较。

著录项

  • 公开/公告号EP0259183A3

    专利类型

  • 公开/公告日1989-06-28

    原文格式PDF

  • 申请/专利权人 LIFETRAC;

    申请/专利号EP19870307844

  • 发明设计人 BAKER FRASER LEE;

    申请日1987-09-04

  • 分类号C12Q1/18;

  • 国家 EP

  • 入库时间 2022-08-22 06:34:43

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号